Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

30% of Consumers Take Action After Viewing Prescription Ads: Study

April 9, 2015 12:52 pm | News | Comments

According to a new survey by Treato.com, nearly 30 percent of consumers have been prompted into action by direct to consumer (DTC) advertising for an Rx (prescription) medication. Read more...

TOPICS:

Prolong Pharmaceuticals' SCD Treatment Gets Orphan Drug Designation

April 9, 2015 12:43 pm | News | Comments

Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its flagship product Sanguinate for the treatment of Sickle Cell Disease (SCD). Read more...

TOPICS:

Cellular Defect Linked to Diabetes

April 9, 2015 12:33 pm | by Columbia University | News | Comments

A cellular defect that can impair the body’s ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center (CUMC) researchers. Read more..

TOPICS:
Advertisement

Researchers Deliver Large Particles into Cells at High Speed

April 9, 2015 12:27 pm | by UCLA | News | Comments

A new device developed by UCLA engineers and doctors may eventually help scientists study the development of disease, enable them to capture improved images of the inside of cells and lead to other improvements in medical and biological research. Read more...

TOPICS:

Scientists Awarded $1.2 Million to Find Cancer Drug Candidates

April 9, 2015 12:20 pm | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $1.2 million from the National Cancer Institute of the National Institutes of Health (NIH) to accelerate the development of drug candidates to curb one of the most important drivers of human cancer. Read more...

TOPICS:

The First Personalized Genomic Cancer Vaccines

April 9, 2015 12:07 pm | by Cynthia Fox, Science Writer | Articles | Comments

The first personalized cancer vaccine using genomics to define targets elicits robust immune responses, says a recent Science study. Read more...

TOPICS:

A Patch for Peanut Allergies

April 9, 2015 11:56 am | by Bevin Fletcher, Associate Editor | News | Comments

French biopharmaceutical company DBV Technologies moves closer to bringing its peanut allergy patch to market, receiving Breakthrough Therapy Designation from the U.S. Food and Drug Administration as it prepares to launch its Phase 3 trial. Read more...

TOPICS:

Vitamin D Link with Depression in Overweight Women

April 9, 2015 8:43 am | by University of Adelaide | News | Comments

Researchers have discovered a previously unknown link between vitamin D and depression in overweight women with polycystic ovary syndrome. Read more...

TOPICS:
Advertisement

Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis

April 9, 2015 8:42 am | News | Comments

Actavis has an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Pharmaceuticals Inc., upon the completion of the Phase 2b study. Read more...

TOPICS:

Biologists Identify Brain Tumor Weakness

April 9, 2015 8:42 am | by Anne Trafton, MIT | News | Comments

Biologists have discovered a vulnerability of brain cancer cells that could be exploited to develop more-effective drugs against brain tumors. Read more...

TOPICS:

Easing the Pain

April 9, 2015 8:41 am | by Queen's University | News | Comments

The combination of two well-known drugs will have unprecedented effects on pain management. Read more...

TOPICS:

Researchers Develop Effective, Single Dose Ebola Vaccine

April 9, 2015 8:41 am | by University of Texas | News | Comments

A team of researchers has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. Read more...

TOPICS:

Allergy Drug Inhibits Hepatitis C in Mice

April 9, 2015 8:41 am | by National Institute of Health | News | Comments

An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice. Read more...

TOPICS:

Novel Antibody Therapy May Suppress HIV Infection

April 8, 2015 1:05 pm | by Stephanie Guzowski, Editor | News | Comments

In a first study to test a new generation of HIV antibodies in humans, an experimental therapy lowered the virus amount in a patient’s blood. The trial results, published in Nature, showed that a single dose of potent antibody, 3BNC117, was well tolerated and temporarily reduced viral loads. Read more...

TOPICS:

Risk of Breast, Ovarian Cancer May Differ By Type of BRCA1, BRCA2 Mutation: Study

April 8, 2015 12:51 pm | by UPenn | News | Comments

In a study involving more than 31,000 women with cancer-causing mutations in the BRCA1 or BRCA2 genes, researchers at the Basser Center for BRCA, the Abramson Cancer Center, and the Perelman School of Medicine at the University of Pennsylvania, identified mutations that are associated with significantly different risks of breast and ovarian cancers. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading